Emerald Advisers, LLC Kal Vista Pharmaceuticals, Inc. Transaction History
Emerald Advisers, LLC
- $2.53 Billion
- Q2 2025
A detailed history of Emerald Advisers, LLC transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, Emerald Advisers, LLC holds 1,038,049 shares of KALV stock, worth $12.7 Million. This represents 0.46% of its overall portfolio holdings.
Number of Shares
1,038,049
Previous 898,190
15.57%
Holding current value
$12.7 Million
Previous $10.4 Million
13.27%
% of portfolio
0.46%
Previous 0.51%
Shares
10 transactions
Others Institutions Holding KALV
# of Institutions
145Shares Held
54.1MCall Options Held
1.19MPut Options Held
6.1K-
Vr Adviser, LLC New York, NY6.7MShares$82.1 Million18.68% of portfolio
-
Tang Capital Management LLC San Diego, CA4.94MShares$60.5 Million3.7% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.91MShares$60.2 Million2.48% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA4.89MShares$59.9 Million3.55% of portfolio
-
Vestal Point Capital, LP New York, NY4.75MShares$58.2 Million3.92% of portfolio
About KalVista Pharmaceuticals, Inc.
- Ticker KALV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,602,000
- Market Cap $301M
- Description
- KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...